Carregando...
Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
The androgen receptor drives the growth of metastatic castration-resistant prostate cancer. This has led to the development of multiple novel drugs targeting this hormone-regulated transcription factor, such as enzalutamide – a potent androgen receptor antagonist. Despite the plethora of possible tr...
Na minha lista:
| Publicado no: | Endocr Relat Cancer |
|---|---|
| Principais autores: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bioscientifica Ltd
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215909/ https://ncbi.nlm.nih.gov/pubmed/30382692 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-18-0289 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|